HEAL Partners

HEAL Partners

Investment Management

Sydney, New South Wales 895 followers

Healthcare and Education (and related Lifestyle) | A Growth Private Equity Fund

About us

HEAL is a growth stage private equity fund manager focused on revenue generating growth businesses in the health, education and related lifestyle sectors with the potential for global scale or industry disruption. Led by a team of proven founders, investors, portfolio managers and operators, we are focused on capitalising on opportunities created by new specialties in developed markets. At HEAL, we are committed to promoting environmental, social and governance (ESG) principles through our investment activities to promote long term sustainability and encourage socially responsible business practices.

Industry
Investment Management
Company size
11-50 employees
Headquarters
Sydney, New South Wales
Type
Privately Held
Founded
2020

Locations

Employees at HEAL Partners

Updates

  • We are excited to announce HEAL Fund II's latest investment - a US$ 15m commitment to Crimson Education. Crimson is the world's leading college admissions consulting platform, helping students from around the world gain access to leading colleges and universities. Crimson also operates Crimson Global Academy, a global, leading online private school, connecting world-class teachers to ambitious students. HEAL first invested in Crimson, through Fund I, three years ago, and have been thrilled with the company's progress and development since. We look forward to building on our relationship with Jamie Beaton and the Crimson team. HEAL Partner, Martin Dalgleish, has joined the board of Crimson as part of this investment.  This investment is the third completed deal for Fund II, following investments in Removery, the world's leading tattoo removal platform headquartered in Austin, Texas, and in The Fertility Partners, Canada's leading fertility platform. We are also in the final stages of diligence for Fund II's fourth investment - further details will be announced in the next few weeks! Fund II recently secured Second Close at ~A$ 200m, i.e. approximately the same size as Fund I, with strong indication of further commitments into Final Close targeted in mid-2025.

    View profile for Jamie Beaton, graphic

    CEO, Crimson Education | Harvard | Stanford | Rhodes | Yale | Princeton | Forbes 30 Under 30

    Excited to share a major milestone for Crimson Education - we have just closed a $67 million Series D led by Movac, and cemented our place as the first K-12 Edtech in Australia and New Zealand to achieve Unicorn status. I am very excited to work with Mark Vivian, Martin Dalgleish and a variety of other outstanding investors and partners including HEAL Partners Five Sigma HighSage Ventures Icehouse Ventures and Tiger Global Management on the next stage of Crimson's global growth. We are also delighted to welcome Hon David Cunliffe, the former leader of the New Zealand Labour Party to our advisory board. David grew up in NZ, won a scholarship to study at United World College and pursued his postgraduate education at Harvard University. He worked at BCG before taking his experience back to New Zealand through government. He is an inspiring example for our young Kiwi Crimson students of leveling up on the world stage and bettering the society that made you who you are. We are pumped to welcome NFL Legend Larry Fitzgerald Jr. as an investor to Crimson. He is inspiring for our students, especially our athletes at Crimson Global Academy. As a Kiwi, it gives me enormous pride to partner up with one of the nation's best venture funds Movac and with one of the leaders in the venture ecosystem in Mark Vivian. Mark and I share a common belief that Kiwis need to compete on the world stage and can't exist in a learning bubble. At a time where truancy is nearing all time highs across New Zealand schools and we have a challenged national curriculum that is years behind rigorous international alternatives like A Levels and the International Baccalaureate, we need innovative options for high school students to achieve their full potential. Crimson Global Academy led by Penelope Barton has already helped young Kiwis like Jade Sceats go from Kerikeri to Princeton University and we're just getting started. Since 2019, we’ve seen significant growth in our accredited online high school which now has nearly 2,000 students from around the world - accessing a flexible and diverse education, taught by 200 world-class teachers. Looking within, what’s also changed for me is how my ambitions have been lifted. I’ve been fortunate to experience what a world-class education looks like, having studied at Harvard University, Stanford University, University of Oxford, Princeton University, and Tsinghua University, a natural accompaniment to building Crimson. As Crimson grows to over a $1bn in valuation and I complete my tenth degree at King's College London, I reflect on what’s changed - but also what’s remained constant. Today, I’m more confident than ever that a world-class education is the best way to expand kids’ horizons and raise their ambitions. Crimson’s greatest contribution is not some kind of magic short cut but a rigorous, world-class education system to unlock a purposeful life, where our students have the confidence and tools to excel on a global stage.

    • No alternative text description for this image
  • HEAL Partners reposted this

    We're proud to continue our collaboration with fund managers to provide a wide range of investment options for advisers and their clients. In September we onboarded several new managed funds onto our platform, offering investors new opportunities to diversify and grow their portfolios. This unlocks new growth avenues for wealth practices. See the list below: * Arnott Opportunities Carbon Fund * Blackwattle Long-Short 130/30 Quality Fund * Hybrid Income Fund * FNC Follow-on Fund * HEAL Partners Australia Fund 2 Pty Ltd * iCapital Private Markets Fund (Hedged) - AUT * iCapital Private Markets Fund (Unhedged) - AUT * Yarra Higher Income Fund * Lazard Select Australian Equity Fund - S Class * Pallas Senior Income Fund * Potentum Global Access Fund * RF CorVal Tottenham Trust * Regal Australian Long Short Equity Fund * Scarcity GP Access Fund Class C * Vanguard Active Positive Impact Fund * iShares MSCI Emerging Markets ex China ETF Arnott Capital Blackwattle Investment Partners Seed Partnerships Future Now Capital HEAL Partners iCapital Yarra Capital Management Lazard Asset Management Pallas Capital Potentum Partners RF Corval Regal Funds Management Scarcity Partners Vanguard Australia iShares

    • No alternative text description for this image
  • View organization page for HEAL Partners, graphic

    895 followers

    We are pleased to announce that Fund II has secured Second Close at ~A$ 200m, i.e. approximately the same size as Fund I, with strong indication of further commitments into Final Close targeted in mid-2025. Fund II has completed two investments to date, in Removery, the world's leading tattoo removal platform headquartered in Austin, Texas, and in The Fertility Partners, Canada's leading fertility platform. Investments #3 and #4 have been secured with completion subject to confirmatory diligence and approvals. Further details to follow over the next few weeks! We would like to thank our incoming and existing investors for their strong support and look forward to a successful partnership! We would also like to welcome Sam Goldwater to Fund II's LPAC. Sam is the Co-Founder and CIO of Generate Investment Management, a New Zealand KiwiSaver and wealth fund manager with approximately A$ 6bn in AUM. We are excited to partner with Generate KiwiSaver Scheme on Fund II! Martin Robinson

    KiwiSaver Generate commits US$25m to HEAL Fund II

    KiwiSaver Generate commits US$25m to HEAL Fund II

    businessdesk.co.nz

  • We are excited for this partnership between HEAL portfolio company, Us2.ai and Advara HeartCare, the largest provider of cardiac healthcare services in Australia, aimed at enhancing heart disease detection, diagnosis and treatment. Us2.ai is a leading provider of AI-automated echocardiography solutions and is on a mission to automate the fight against heart disease. The company’s advanced AI algorithms assist healthcare professionals in diagnosing and treating heart disease more accurately and efficiently, and integrate seamlessly into clinical workflows, providing valuable insights that improve patient care and outcomes.  

Similar pages

Browse jobs